Scopus BioPharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure7.1yrs

Recent management updates

Recent updates

Scopus Bio files application for immuno-oncology RNA therapy in U.S.

Apr 26

Do Institutions Own Scopus BioPharma Inc. (NASDAQ:SCPS) Shares?

Mar 16
Do Institutions Own Scopus BioPharma Inc. (NASDAQ:SCPS) Shares?

CEO

Scopus BioPharma has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Ira Greenspan
Senior Advisor & Director7.6yrsUS$200.00k0.40%
$ 51.1
Robert Gibson
Vice Chairman7.6yrsUS$200.00k0.50%
$ 63.7
David Buckel
Independent Director3.9yrsUS$55.00k0%
$ 0
Aharon Schwartz
Member of Scientific Advisory Boardno datano datano data
Raphael Hofstein
Independent Director2.5yrsUS$41.33kno data
David Weild
Independent Director3.9yrsUS$55.00k0%
$ 0
George Kunos
Member of Scientific Advisory Board7.1yrsno datano data
Joshua Lamstein
Chairman7.6yrsUS$231.08k0.29%
$ 36.0
Joseph Tam
Member of Scientific Advisory Board6.1yrsno datano data
Robert Spiera
Member of Scientific Advisory Board7.1yrsno datano data
Yair Levy
Member of Scientific Advisory Board7.1yrsno datano data
Hua Yu
Member of Scientific Advisory Boardno datano datano data

7.1yrs

Average Tenure

66yo

Average Age

Experienced Board: SCPS's board of directors are considered experienced (7.1 years average tenure).